Immunotherapy is among the newest and most potent weapons against cancer. It prompts the immune system to recognize tumors as intruders in the body and attack. But not all patients respond well to immunotherapy. Why? Scientists aren’t always sure.
Evidence of Safety, Efficacy for Salvaged Blood Irradiators Lacking, FDA Staff Say
Ahead of the Radiological Devices Advisory Panel meeting on Tuesday, FDA reviewers noted that the agency’s proposal to classify salvaged blood irradiators as high-risk Class
November 4, 2023